The US Centers for Medicare and Medicaid Services (CMS) has announced that the late enrollment penalty for the Medicare Part D prescription drug benefit will once again be waived for low-income beneficiaires (Marketletters passim). The decision was welcomed as "a good move" by Senator Charles Grassley (Republican, Iowa), who previously sponsored legislation to abolish the penalty for all applicants.
Acting CMS Administrator, Leslie Norwalk, explained the decision: "this is our most difficult population to reach and the one for which we continue to focus our efforts." Last year, the first for which the prescription drug benefit was implemented, enrollment rates for low-income patients were lower than for the higher-income population.
30 million hits on drug benefit web site
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze